| 33.65 1.31 (4.05%) | 03-10 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 41.05 | 1-year : | 47.95 |
| Resists | First : | 35.15 | Second : | 41.05 |
| Pivot price | 33.26  |
|||
| Supports | First : | 32.39 |
Second : | 30.7 |
| MAs | MA(5) : | 33.29  |
MA(20) : | 33.32 |
| MA(100) : | 30.38 |
MA(250) : | 25.96 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 38.5 |
D(3) : | 43.7 |
| RSI | RSI(14): 54.4 |
|||
| 52-week | High : | 37.43 | Low : | 18.5 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ GRDN ] has closed below upper band by 36.6%. Bollinger Bands are 29.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 34.17 - 34.3 | 34.3 - 34.45 |
| Low: | 31.12 - 31.26 | 31.26 - 31.41 |
| Close: | 33.39 - 33.61 | 33.61 - 33.87 |
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
Tue, 10 Mar 2026
Guardian Pharmacy Services, Inc. to Participate in Upcoming Oppenheimer Healthcare MedTech & Services Conference - marketscreener.com
Tue, 10 Mar 2026
Guardian Pharmacy Services, Inc. to Participate in Upcoming Oppenheimer Healthcare MedTech & Services Conference - bdtonline.com
Fri, 06 Mar 2026
A Look At Guardian Pharmacy Services (GRDN) Valuation As Growth And M&A Support Long Term Care Expansion - simplywall.st
Thu, 05 Mar 2026
All You Need to Know About Guardian Pharmacy (GRDN) Rating Upgrade to Buy - Yahoo Finance
Thu, 05 Mar 2026
Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Wed, 04 Mar 2026
Guardian Pharmacy Services (GRDN) to Release Quarterly Earnings on Wednesday - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 36 (M) |
| Shares Float | 23 (M) |
| Held by Insiders | 37.9 (%) |
| Held by Institutions | 57.1 (%) |
| Shares Short | 1,870 (K) |
| Shares Short P.Month | 1,540 (K) |
| EPS | 0.68 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.9 |
| Profit Margin | 2.9 % |
| Operating Margin | 4.4 % |
| Return on Assets (ttm) | 10.5 % |
| Return on Equity (ttm) | 24 % |
| Qtrly Rev. Growth | 20 % |
| Gross Profit (p.s.) | 7.56 |
| Sales Per Share | 38.34 |
| EBITDA (p.s.) | 2.31 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 88 (M) |
| Levered Free Cash Flow | 57 (M) |
| PE Ratio | 49.48 |
| PEG Ratio | 0 |
| Price to Book value | 11.6 |
| Price to Sales | 0.87 |
| Price to Cash Flow | 13.86 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|